StockDuty ← Dashboard Oct 01, 2026 06:39 AM ET
SignalCorporate

COLLPLANT BIOTECHNOLOGIES GAAP EPS OF -$0.87, REVENUE OF $11.43M; REAFFIRMS FY 2026 OUTLOOK - SEEKINGALPHA

Reaffirmed FY 2026 outlook alongside $11.43M revenue signals forward guidance confidence.

Reaffirmed FY 2026 outlook alongside $11.43M revenue signals forward guidance confidence.
Reaffirmed FY 2026 outlook alongside $11.43M revenue signals forward guidance confidence. — impact context not separately stored; see What changed.
Sources